Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11567200rdf:typepubmed:Citationlld:pubmed
pubmed-article:11567200lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C1556084lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0065828lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C1551362lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C1999244lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0580836lld:lifeskim
pubmed-article:11567200lifeskim:mentionsumls-concept:C0079170lld:lifeskim
pubmed-article:11567200pubmed:issue4lld:pubmed
pubmed-article:11567200pubmed:dateCreated2001-9-21lld:pubmed
pubmed-article:11567200pubmed:abstractTextThe aims of our study were to estimate the measle-mumps-rubella (MMR) vaccine coverage in 3 years old children in 12 French countees, to document the evolution between 1997 and 1999 in two groups of 6 countees (pilot group and control group) before and after the implementation of promotion programmes in the pilot group, and to identify factors related to measle-mumps-rubella vaccination.lld:pubmed
pubmed-article:11567200pubmed:languagefrelld:pubmed
pubmed-article:11567200pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11567200pubmed:citationSubsetIMlld:pubmed
pubmed-article:11567200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11567200pubmed:statusMEDLINElld:pubmed
pubmed-article:11567200pubmed:monthSeplld:pubmed
pubmed-article:11567200pubmed:issn0398-7620lld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:MayerCClld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:ChabaudFFlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:GarrosBBlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:BaudierFFlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:FontaineDDlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:LepeePPlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:RotilyMMlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:LedesertBBlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:ArrighiJJlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:JanvrinM PMPlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:WoronoffA SASlld:pubmed
pubmed-article:11567200pubmed:authorpubmed-author:GuagliardoVVlld:pubmed
pubmed-article:11567200pubmed:issnTypePrintlld:pubmed
pubmed-article:11567200pubmed:volume49lld:pubmed
pubmed-article:11567200pubmed:ownerNLMlld:pubmed
pubmed-article:11567200pubmed:authorsCompleteYlld:pubmed
pubmed-article:11567200pubmed:pagination331-41lld:pubmed
pubmed-article:11567200pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:meshHeadingpubmed-meshheading:11567200...lld:pubmed
pubmed-article:11567200pubmed:year2001lld:pubmed
pubmed-article:11567200pubmed:articleTitle[Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].lld:pubmed
pubmed-article:11567200pubmed:affiliationObservatoire Régional de la Santé PACA-INSERM U379, 23, rue Stanislas Torrents, 13006 Marseille, France.lld:pubmed
pubmed-article:11567200pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11567200pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11567200pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11567200pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:11567200pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11567200pubmed:publicationTypeMulticenter Studylld:pubmed